Saluting Self-Testers

Saluting Self-Testers I found the article "Heal Thyself or Die Trying"1 particularly interesting because my father, Richard K. Bernstein, MD, developed blood glucose while self-monitoring for diabetes almost 30 years ago. A Type-1 diabetic from age 12, Dr. Bernstein was beginning to suffer from diabetic complications in his 30's. Using a cumbersome, first-generation blood glucose monitoring device available only to hospital emergency rooms (to distinguish comatose diabetics from drunks), h

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

I found the article "Heal Thyself or Die Trying"1 particularly interesting because my father, Richard K. Bernstein, MD, developed blood glucose while self-monitoring for diabetes almost 30 years ago. A Type-1 diabetic from age 12, Dr. Bernstein was beginning to suffer from diabetic complications in his 30's. Using a cumbersome, first-generation blood glucose monitoring device available only to hospital emergency rooms (to distinguish comatose diabetics from drunks), he learned to control his diabetes by appropriately titering his insulin and adjusting his diet. Although successful small-scale trials of his methods were conducted at New York's Rockefeller University, physicians remained reluctant to promote my father's approaches, which included adherence to a high protein/low carbohydrate diet and multiple small doses of insulin daily. Diabetologists feared the possibility of hypoglycemia (low blood sugars) in patients attempting to maintain normal blood sugars.

At age 45, my father left successful careers in biomedical engineering and management ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Julie Bernstein

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours